The Department of Licensing and Regulatory Affairs announced March 11 it has approved adding cerebral palsy to the list of debilitating medical conditions covered by the Michigan Medical Marihuana Act of 2008. Cerebral palsy was approved by LARA after the Medical Marihuana Review Panel members unanimously recommended approval; the agency denied the condition of Chronic Aggressive Behavior after panel members unanimously recommended denial.
The Medical Marihuana Review Panel made its recommendations to the department after receiving citizen comments in February on the petitions to add these two conditions to the list of debilitating medical conditions identified in the act. The approval or denial of the petitions by the department are considered final department actions.
Effective immediately, cerebral palsy is now added to the following current list of debilitating medical conditions already approved for medical marijuana in Michigan:
Acquired Immune Deficiency Syndrome
Agitation of Alzheimer's disease
Amyotrophic Lateral Sclerosis
Inflammatory Bowel Disease
Obsessive Compulsive Disorder
Positive status for Human Immunodeficiency Virus
Post-Traumatic Stress Disorder
Spinal Cord Injury
A chronic or debilitating disease or medical condition or its treatment that produces one or more of the following: Cachexia or Wasting Syndrome; Severe and Chronic Pain; Severe Nausea; Seizures, including but not limited to those characteristic of epilepsy; Severe and persistent muscle spasms, including but not limited to those characteristic of multiple sclerosis
Disclaimer: The American Medical Marijuana Physicians Association does not publish membership information. Our goal is to ensure that community physicians have the tools and resources they need to safely and effectively recommend medical marijuana as a last resort alternative treatment. Physicians should utilize this alternative recommendation based on evidence when available and always educate the patient on potential risks and other treatment options. The American Medical Marijuana Physicians Association supports the need for more research into cannabinoid medicine as more high quality studies are needed. By accessing any page on this site you agree to the Site Terms and Conditions of Use.